Optimizing factor VIII dosing in obese individuals with haemophilia A

Blood Coagul Fibrinolysis. 2021 Oct 1;32(7):528-530. doi: 10.1097/MBC.0000000000001067.

Authors

Richard Curtis Godby¹, Dheeraj Raju², Felipe Massicano¹, Lance A Williams³, Briley Black¹, David Dorn⁴, Marisa B Marques¹

Affiliations

¹ Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
² Cancer Treatment Centers of America, Boca Raton, Florida.
³ Department of Pathology, Division of Laboratory Medicine, Mayo Clinic, Phoenix, Arizona.
⁴ Cunningham Pathology, Tuscaloosa, Alabama, USA.

PMID: 34285174
DOI: 10.1097/MBC.0000000000001067

No abstract available

MeSH terms

Factor VIII
Hemophilia A* / complications
Hemostatics*
Humans
Obesity / complications

Substances

Hemostatics
Factor VIII